ASTRAZEN.NSE logo

ASTRAZEN.NSEAstraZeneca Pharma India Ltd.

8,419.00
194.00
(2.25%)
Today
Updated: 04:00 PM GMT+5:30
Mkt Cap214.96B
Vol5,109.00
News
all
press releases
AstraZeneca Champions Next‑Gen Cardiologists Through India Coronary Conquest 2026
AstraZeneca Pharma India Ltd., in collaboration with … . Sandeep Arora, Director, Medical Affairs, AstraZeneca Pharma India Ltd. “India Coronary Conquest … embodies AstraZeneca ’s purpose, to push the boundaries …
cityfalcon.com
News Placeholder
More News
News Placeholder
AstraZeneca Champions Next‑Gen Cardiologists Through India Coronary Conquest 2026
AstraZeneca Pharma India Ltd., in collaboration with … . Sandeep Arora, Director, Medical Affairs, AstraZeneca Pharma India Ltd. “India Coronary Conquest … embodies AstraZeneca ’s purpose, to push the boundaries …
cityfalcon.com
News Placeholder
AstraZeneca India Announces ₹3,400 Crore Sale of Bengaluru Landholding
AstraZeneca Pharma India is … Real Estate Development Earlier, AstraZeneca had explored the possibility … indicated. Strategic Role of AstraZeneca ’s Bengaluru Facility The … monitoring and regulatory compliance. AstraZeneca Pharma India, established in 1979 …
cityfalcon.com
News Placeholder
AstraZeneca India Announces ₹3,400 Crore Sale of Bengaluru Landholding
AstraZeneca Pharma India is … Real Estate Development Earlier, AstraZeneca had explored the possibility … indicated. Strategic Role of AstraZeneca ’s Bengaluru Facility The … monitoring and regulatory compliance. AstraZeneca Pharma India, established in 1979 …
cityfalcon.com
News Placeholder
AstraZeneca Pharma India Wins New Approval for Calquence Use in Untreated CLL and SLL
AstraZeneca Pharma India Limited ( ($IN:ASTRAZEN) ) has shared an announcement. AstraZeneca Pharma India has received permission from India’s Centr...
cityfalcon.com
News Placeholder
AstraZeneca Pharma India Wins New Approval for Calquence Use in Untreated CLL and SLL
AstraZeneca Pharma India Limited ( ($IN:ASTRAZEN) ) has shared an announcement. AstraZeneca Pharma India has received permission from India’s Centr...
cityfalcon.com
News Placeholder
AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 crore
The land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva Group, Aurobindo Pharma and RMZ. The company is looking to sell it as part of a broader land monetisation strategy.
cityfalcon.com
News Placeholder
AstraZeneca India plans to sell 64-acre Bengaluru site for Rs 3,400 crore
The land parcel, expected to fetch about ₹3,400 crore for AstraZeneca Pharma India, has drawn interest from developers including the Sattva Group, Aurobindo Pharma and RMZ. The company is looking to sell it as part of a broader land monetisation strategy.
cityfalcon.com
News Placeholder
AstraZeneca, Telangana govt to roll out AI-powered lung cancer screening in public hospitals
Hyderabad: AstraZeneca Pharma India, a subsidiary of British-Swedish pharma giant AstraZeneca Plc, has signed a memorandum of understanding with the T.
cityfalcon.com
News Placeholder
AstraZeneca, Telangana govt to roll out AI-powered lung cancer screening in public hospitals
Hyderabad: AstraZeneca Pharma India, a subsidiary of British-Swedish pharma giant AstraZeneca Plc, has signed a memorandum of understanding with the T.
cityfalcon.com
<
1
2
...
>